Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2003
02/13/2003WO2003012126A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
02/13/2003WO2003012124A2 Methods for immobilizing molecules to a solid phase and uses thereof
02/13/2003WO2003012123A2 Antisense modulation of dual specific phosphatase 9 expression
02/13/2003WO2003012119A2 Nucleic acid amplification method
02/13/2003WO2003012117A1 Dna vaccine
02/13/2003WO2003012116A2 Caax prenyl protease nucleic acids and polypeptides and methods of use thereof
02/13/2003WO2003012115A2 Dna molecules encoding herbicide tolerant acetolactate synthase
02/13/2003WO2003012114A2 Methods of rna and protein synthesis
02/13/2003WO2003012113A2 Inducible expression systems employing ppar transcriptional activators
02/13/2003WO2003012112A1 Methylation resistant vectors
02/13/2003WO2003012111A2 Conjugates for the modulation of immune responses
02/13/2003WO2003012110A1 Thermal tolerant mannanase from acidothermus cellulolyticus
02/13/2003WO2003012109A1 Thermal tolerant cellulase from acidothermus cellulolyticus
02/13/2003WO2003012108A2 Uses of a thyx polypeptide or a nucleic acid encoding such a polypeptide, in particular for screening anti-bacterial or anti-viral compounds
02/13/2003WO2003012107A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
02/13/2003WO2003012106A2 Regulating nucleic acid for expressing a polynucleotide of interest specifically in the endothelium of a plant seed and uses thereof
02/13/2003WO2003012105A2 Vegf isoform
02/13/2003WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof
02/13/2003WO2003012103A2 Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses
02/13/2003WO2003012102A2 Nucleic acids coding for novel hect domain proteins, their diagnostic and therapeutic uses
02/13/2003WO2003012101A1 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production
02/13/2003WO2003012100A2 Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids
02/13/2003WO2003012099A1 Chondroitin synthase
02/13/2003WO2003012098A1 Modified yeast showing high secretion productivity of foreign protein and process for producing foreign protein using the yeast
02/13/2003WO2003012097A2 Methods of inhibiting dna replication
02/13/2003WO2003012096A2 Plant stress regulated genes
02/13/2003WO2003012095A1 Thermal tolerant exoglucanase from acidothermus cellulolyticus
02/13/2003WO2003012094A1 Process for xylanase production
02/13/2003WO2003012093A2 Regulator of calcineurin
02/13/2003WO2003012092A1 Method for producing arachidonic acid in transgenic organisms
02/13/2003WO2003012091A2 Fatty acid desaturase gene obtained from pomegranate and method for the production of unsaturated fatty acids
02/13/2003WO2003012090A2 Thermal tolerant avicelase from acidothermus cellulolyticus
02/13/2003WO2003012089A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
02/13/2003WO2003012086A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines
02/13/2003WO2003012085A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines
02/13/2003WO2003012082A2 Method for modulating stem cell differentiation using stem loop rna
02/13/2003WO2003012078A2 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
02/13/2003WO2003012071A2 Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use
02/13/2003WO2003012069A2 Compositions and methods for generating chimeric heteromultimers
02/13/2003WO2003012068A2 Novel fusion proteins and assays for molecular binding
02/13/2003WO2003012067A2 Expression profile of prostate cancer
02/13/2003WO2003012066A2 Magnesium precipitate hot start method for molecular manipulation of nucleic acids
02/13/2003WO2003012064A2 Nucleic acids and encoded polypeptides associated with bipolar disorder
02/13/2003WO2003012063A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof
02/13/2003WO2003012062A2 Animal model with disrupted fgf14 gene
02/13/2003WO2003012059A2 Antisense modulation of cyclin d2 expression
02/13/2003WO2003012057A2 Antisense modulation of serum amyloid a4 expression
02/13/2003WO2003012056A2 Carotenoid ketolase gene
02/13/2003WO2003012054A2 Methods and compositions relating to improved lentiviral vector production systems
02/13/2003WO2003012052A2 Specific inhibition of gene expression by small double stranded rnas
02/13/2003WO2003012051A2 Inhibitor of dna methylation
02/13/2003WO2003012050A2 Mitochondrial genome replenishment
02/13/2003WO2003012045A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
02/13/2003WO2003012044A2 Hagfish cathelin-associated antimicrobial peptides and genes
02/13/2003WO2003012042A2 Ratio-based oligonucleotide probe selection
02/13/2003WO2003012041A2 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit
02/13/2003WO2003012036A2 Systems for in vivo site-directed mutagenesis using oligonucleotides
02/13/2003WO2003012035A2 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
02/13/2003WO2003012033A2 Antisense modulation of short heterodimer partner-1 expression
02/13/2003WO2003012032A2 Antisense modulation of p70 s6 kinase expression
02/13/2003WO2003012031A2 Antisense modulation of stearoyl-coa desaturase expression
02/13/2003WO2003012030A2 Isoform-selective inhibitors and activators of pde3 cyclic
02/13/2003WO2003012028A2 Line retrotransposable elements with rnase h enzyme activity and use of same
02/13/2003WO2003011908A2 Mutant forms of the tgf-b type ii receptor which bind all tgf-b isoforms and the use thereof
02/13/2003WO2003011907A2 Receptor, the use thereof, and mouse antibodies
02/13/2003WO2003011906A2 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
02/13/2003WO2003011905A1 Novel serine protease
02/13/2003WO2003011903A2 Identification of specific tumor antigens by means of the selection of cdna libraries with sera
02/13/2003WO2003011902A1 Identification of specific tumour antigens by selection of cdna libraries with sera
02/13/2003WO2003011899A2 Antigenic polypeptides
02/13/2003WO2003011898A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
02/13/2003WO2003011895A2 Compositions and methods for modulation of immune responses
02/13/2003WO2003011893A2 Immunologically significant herpes simplex virus antigens and methods for using same
02/13/2003WO2003011890A1 Antisense modulation of corest expression
02/13/2003WO2003011889A2 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression
02/13/2003WO2003011888A1 Antisense modulation of sap-1 expression
02/13/2003WO2003011887A2 Antisense modulation of apolipoprotein b expression
02/13/2003WO2003011878A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
02/13/2003WO2003011823A2 Crfr1 selective ligands
02/13/2003WO2003011334A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv
02/13/2003WO2003011332A1 Methods relating to improved polyepitope vaccination strategies
02/13/2003WO2003011331A2 Materials and methods relating to improved vaccination strategies
02/13/2003WO2003011328A1 Pregnancy-related enzyme activity
02/13/2003WO2003011326A1 Use of long pentraxin ptx3 for treating female infertility
02/13/2003WO2003011317A1 Modulators of notch signalling for use in immunotherapy
02/13/2003WO2003011315A1 Composition for inhibiting tyrosine kinase activity of src proteins
02/13/2003WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity
02/13/2003WO2003011230A2 Modified reoviral therapy
02/13/2003WO2003011220A2 Animal model for fatty acid amide-related neurobehaviors
02/13/2003WO2003011219A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
02/13/2003WO2003011213A2 Method for treating diabetes and obesity
02/13/2003WO2003011211A2 Peg-modified uricase
02/13/2003WO2003011209A2 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes
02/13/2003WO2003011200A2 Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity
02/13/2003WO2003011020A1 Imaging marker transgenes
02/13/2003WO2003011019A2 Lethal mouse model for testing of pharmaceuticals and vaccines against neospororis
02/13/2003WO2003011016A2 Genetically modified cows having reduced susceptibility to mad cow disease
02/13/2003WO2003011015A2 Methods for improving seed and grain characteristics
02/13/2003WO2003011014A2 Novel constitutive and tissue specific plant promoters and their utilization
02/13/2003WO2003004595A9 Materials and methods relating to protein and nucleic acid evolution
1 ... 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 ... 4023